Provide Earlier Answers For Families With Autism Risk Testing
NeuroQure offers a groundbreaking autism risk test, ASD Insight™, designed for early risk detection of autism spectrum disorder (ASD). Equip your practice with the tools to help families understand their child's developmental journey.
Test Requisition Form (TRF)
The most efficient way to place an order is through our online portal. Alternatively, you can submit a test request by completing the TRF form linked below. If you have any questions, please contact our support team at support@neuroqure.com.
For streamlined ordering and enhanced features, access our Health Provider Portal by registering here.
Advance Patient Care Through Early Detection
The ASD Insight™ test integrates seamlessly into standard pediatric and obstetric care pathways, requiring only a 3mm skin biopsy or discarded circumcision tissue. Sample collection can occur as early as birth, with results available within weeks of sample receipt.
The test complements rather than replaces standard autism screening protocols, providing early risk stratification that enables early intervention planning.
Why Add ASD Insight™ To Your Practice?
Provide clarity and support to families with answers, available earlier than ever with first-of-its-kind test.
Our test utilizes advanced technology for autism risk detection based on a biologic marker.
Research shows that early diagnosis of and interventions for autism are more likely to have major long-term positive effects on symptoms and later skills.
Order ASD Insight™ Risk Testing for Autism
Ordering NeuroQure's ASD Insight™ test is simple and efficient. Our streamlined process ensures you can quickly integrate this risk evaluation test into your practice.
Provide your patients with access to a state-of-the-art autism risk assessment test. Best yet, NeuroQure has genetic counselors to support patient result interpretation.
Why Test For ASD Risk?
Know Earlier
By screening at birth, families are able to plan early intervention, enabling access to developmental therapies during critical neuroplasticity windows when intervention efficacy is maximized.
Act Sooner
Published research demonstrates that early intervention beginning before age 2 results in average IQ improvements of 17+ points compared to standard care initiated at typical diagnosis age.
NeuroQure Adheres to Rigorous Quality Standards
At NeuroQure, we pride ourselves on clinical-grade quality in every aspect of our testing process. Our state-of-the-art skin sample test is conducted in our laboratory, ensuring the highest standards of accuracy and reliability.
We employ cutting-edge methodologies tailored specifically for our autism risk test. This commitment to excellence means that physicians and patients alike can trust the our test results.
By adhering to these rigorous quality standards, NeuroQure continues to lead the way in innovative autism risk testing, providing actionable insights that have the potential to impact better patient outcomes.
Need More Information?
Get in touch with our team.